The approval adds compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor and expands the system’s indications for use to people with type 1 diabetes during pregnancy and to adults with type 2 diabetes in Canada. Compatibility with the FreeStyle Libre 3 Plus Sensor and availability of the expanded indications are expected in the second quarter of 2027.
The FreeStyle Libre 3 Plus Sensor can be worn for up to 15 days and sends glucose readings to the pump every minute, with data also available on the Tandem t:slim mobile app. The t:slim X2 pump is powered by Control-IQ+ technology, which adjusts insulin every five minutes based on predicted glucose values, and Tandem described it as the only system with the AutoBolus feature that calculates and delivers a correction bolus to help with missed meal boluses.